WO2015112168A3 - Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier - Google Patents

Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier Download PDF

Info

Publication number
WO2015112168A3
WO2015112168A3 PCT/US2014/013063 US2014013063W WO2015112168A3 WO 2015112168 A3 WO2015112168 A3 WO 2015112168A3 US 2014013063 W US2014013063 W US 2014013063W WO 2015112168 A3 WO2015112168 A3 WO 2015112168A3
Authority
WO
WIPO (PCT)
Prior art keywords
noribogaine
excipient
compositions
brain barrier
blood brain
Prior art date
Application number
PCT/US2014/013063
Other languages
French (fr)
Other versions
WO2015112168A2 (en
Inventor
Deborah C. Mash
JR. Richard D. GLESS
Original Assignee
Demerx, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Demerx, Inc. filed Critical Demerx, Inc.
Priority to EP14880182.2A priority Critical patent/EP3096794A2/en
Priority to PCT/US2014/013063 priority patent/WO2015112168A2/en
Priority to AU2014379612A priority patent/AU2014379612A1/en
Publication of WO2015112168A2 publication Critical patent/WO2015112168A2/en
Publication of WO2015112168A3 publication Critical patent/WO2015112168A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings

Abstract

This invention relates generally to compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier.
PCT/US2014/013063 2014-01-24 2014-01-24 Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier WO2015112168A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP14880182.2A EP3096794A2 (en) 2014-01-24 2014-01-24 Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
PCT/US2014/013063 WO2015112168A2 (en) 2014-01-24 2014-01-24 Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
AU2014379612A AU2014379612A1 (en) 2014-01-24 2014-01-24 Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2014/013063 WO2015112168A2 (en) 2014-01-24 2014-01-24 Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier

Publications (2)

Publication Number Publication Date
WO2015112168A2 WO2015112168A2 (en) 2015-07-30
WO2015112168A3 true WO2015112168A3 (en) 2015-11-26

Family

ID=53682084

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/013063 WO2015112168A2 (en) 2014-01-24 2014-01-24 Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier

Country Status (3)

Country Link
EP (1) EP3096794A2 (en)
AU (1) AU2014379612A1 (en)
WO (1) WO2015112168A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
WO2020212948A1 (en) 2019-04-17 2020-10-22 Compass Pathfinder Limited Methods of treating neurocognitive disorders, chronic pain and reducing inflammation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591738A (en) * 1994-10-14 1997-01-07 Nda International, Inc. Method of treating chemical dependency using β-carboline alkaloids, derivatives and salts thereof
US5925634A (en) * 1989-10-20 1999-07-20 Washington University Use of ibogaine for treating neuropathic pain
US6348456B1 (en) * 1994-07-25 2002-02-19 Deborah C. Mash Method of treating chemical dependency in mammals and a composition therefor
US8637648B1 (en) * 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925634A (en) * 1989-10-20 1999-07-20 Washington University Use of ibogaine for treating neuropathic pain
US6348456B1 (en) * 1994-07-25 2002-02-19 Deborah C. Mash Method of treating chemical dependency in mammals and a composition therefor
US5591738A (en) * 1994-10-14 1997-01-07 Nda International, Inc. Method of treating chemical dependency using β-carboline alkaloids, derivatives and salts thereof
US8637648B1 (en) * 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PETERSON, A. L. ET AL.: "Treatment of Parkinson's disease with trophic factors.", NEUROTHERAPEUTICS, vol. 5, no. 2, 2008, pages 270 - 280, XP022577726 *
PLOS ONE, vol. 7, no. Issue 12, 2012 *

Also Published As

Publication number Publication date
AU2014379612A1 (en) 2016-08-11
EP3096794A2 (en) 2016-11-30
WO2015112168A2 (en) 2015-07-30

Similar Documents

Publication Publication Date Title
WO2015168019A3 (en) Anti-ptk7 antibody-drug conjugates
PT3426226T (en) Ophthalmological composition
EP3345473A4 (en) Combine harvester
EP3474653A4 (en) Harvester
EP3505202A4 (en) Medical equipment package
EP3556343A4 (en) Oil-in-water type composition
EP3351087A4 (en) Combine harvester
EP3234549A4 (en) Diagnostic chip
GB201600990D0 (en) Pharmaceutical or nutritional combination
EP3437644A4 (en) Medicine
IL248773B (en) 1,6-naphthyridine-4,5-dione derivatives and pharmaceutical compositions comprising them
EP3299034A4 (en) Sterilization case
IL252683A0 (en) Substituted pyridyl-cycloalkyl-carboxylic acids, compositions containing them and medical uses thereof
EP3476198A4 (en) Combine harvester
EP3527216A4 (en) Medicine
EP3230748A4 (en) Diagnostic chip
EP3527133A4 (en) Audiometer
EP3406230A4 (en) Cannula
EP3272204A4 (en) Combine harvester
EP3230721A4 (en) Diagnostic chip
WO2015112168A3 (en) Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
EP3525601A4 (en) Reconstituted cereal-legume kernels
PT3445377T (en) Compositions for the skin
GB201621956D0 (en) The artifact
AU2017131V (en) Sunbel 871 Calibrachoa hybrid

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2014379612

Country of ref document: AU

Date of ref document: 20140124

Kind code of ref document: A

REEP Request for entry into the european phase

Ref document number: 2014880182

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2014880182

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14880182

Country of ref document: EP

Kind code of ref document: A2